Menopause Completed Phase 4 Trials for Hydrochlorothiazide (DB00999)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03921736Reversal of an Unfavorable Effect of Hydrochlorothiazide Compared to Angiotensin Converting Enzyme Inhibitor on Serum Uric Acid and Oxypurines Levels by Estrogen-progestin Therapy in Hypertensive Postmenopausal Women.Treatment